Tuesday, 02 January 2024 12:17 GMT

Coloplast A/S - Financial Calendar 2025-26


(MENAFN- GlobeNewsWire - Nasdaq) Please see enclosed pdf.

For more information and calendar invitations for upcoming events, please visit:

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

For further information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Kristine Husted Munk
Senior Director, Investor Relations
Tel. +45 4911 1800 / +45 4911 3266
Email: ...

Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2981
Email: ...

Press and media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: ...

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.

Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Voice and Respiratory Care, Wound and Tissue Repair and Interventional Urology.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2025-09.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment

  • 08_2025_Financial Calendar_2025-26

MENAFN30092025004107003653ID1110130329

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search